CDK-TCIP2
Product Specifications
Target
Bcl-6, CDK
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint
Bioactivity
DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.
Smiles
C(F)(F)(F)C1=C2C(CN(C[C@H]3C[C@@H](C(F)(F)F)CCC3)C2=O)=NC(N)=N1
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15233740 1 Vial
Lentiviral mouse Pde6g shRNA (UAS) - Lentiviral mouse Pde6g shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
